NXL — Nexalin Technology Balance Sheet
0.000.00%
- $16.02m
- $13.97m
- $0.17m
Annual balance sheet for Nexalin Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.078 | 0.662 | 6.99 | 2.95 | 3.48 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.007 | 0.016 | 0.005 | 0.009 | 0.013 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.117 | 0.753 | 7.43 | 3.43 | 3.96 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0.001 | 0.007 | 0.001 | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 0.118 | 0.754 | 7.43 | 3.63 | 4.22 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.57 | 2.36 | 1.95 | 0.425 | 0.547 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.71 | 2.44 | 1.95 | 0.425 | 0.547 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.59 | -1.68 | 5.48 | 3.21 | 3.68 |
Total Liabilities & Shareholders' Equity | 0.118 | 0.754 | 7.43 | 3.63 | 4.22 |
Total Common Shares Outstanding |